High-dose, adjuvanted flu vaccines better protect seniors from symptoms, hospital stays, study finds
Adjusted comparative vaccine effectiveness against medical visits in the high-dose, adjuvanted, and standard-dose cell-based vaccine groups were 9%, 17%, and −6%, respectively.